Clinical Trials
15 trialsNCT06101134 2026-04-09
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Bristol-Myers Squibb
Phase 2 Active not recruiting
NCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT05573022 2025-11-17
IMPACTT
Vejle Hospital
Phase NA Completed
NCT07158892 2025-09-08
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
University of Texas at Austin
Phase NA Not yet recruiting
NCT05883956 2025-03-20
PREFER-HMA
Otsuka Australia Pharmaceutical Pty Ltd
Phase 3 Active not recruiting
NCT05618912 2024-12-11
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Indiana University
Phase NA Completed
NCT04088968 2024-03-22
STRONG-CS
Bispebjerg Hospital
Phase NA Unknown
NCT04409288 2024-01-05
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer
Chinese University of Hong Kong
Phase 3 Terminated
NCT04936243 2022-12-20
TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)
Dana-Farber Cancer Institute
Phase NA Completed
NCT01906073 2020-12-10
NFCP-2
Norwegian University of Science and Technology
Phase 3 Withdrawn
NCT02032550 2020-08-04
Treatment Preference and Patient Centered Prostate Cancer Care
University of Pennsylvania
Phase NA Completed
NCT00595218 2017-07-25
Patient Preference Survey for Radiation Oncologists
University of Pittsburgh
Phase NA Completed
NCT01064310 2017-04-17
PISCES
Novartis
Phase 3 Completed
NCT01596582 2017-03-21
Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening
Boston Medical Center
Phase NA Completed
NCT00810771 2015-06-02
EPIIC
VA Office of Research and Development
Phase NA Completed